Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bloomston

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
American Journal of Surgery|November 6, 2003
Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitroAlan J Durkin, P Mark Bloomston, Alexander S Rosemurgy, et al.
Annals of Surgical Oncology|April 9, 2004
Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsiesMark Bloomston, Alan Durkin, Ivana Yang, et al.
Annals of Surgical Oncology|November 3, 2006
Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancerMark Bloomston, E Christopher Ellison, Peter Muscarella, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 19, 2006
Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreasMark Bloomston, Peter Muscarella, Manisha H Shah, et al.
Pancreas|September 28, 2006
Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resectionMark Bloomston, Tanios S Bekaii-Saab, Kavitha Kosuri, et al.
Journal of the American College of Surgeons|October 27, 2004
Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumorsAlan J Durkin, Mark Bloomston, Timothy J Yeatman, et al.
Annals of Surgical Oncology|December 31, 2011
Repeat hepatectomy for metastatic colorectal cancer is safe but marginally effectiveNatalie B Jones, Megan E McNally, Lavina Malhotra, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinomaMegan E McNally, Amy Collins, Sylwia E Wojcik, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreasMarisa E Hill, Xiaobai Li, Sharon Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 16, 2013
Gastrectomy in advanced gastric cancer effectively palliates symptoms and may improve survival in select patientsAmy Collins, Ioannis Hatzaras, Carl Schmidt, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
American Journal of Surgery|November 6, 2003
Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitroAlan J Durkin, P Mark Bloomston, Alexander S Rosemurgy, et al.
Annals of Surgical Oncology|April 9, 2004
Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsiesMark Bloomston, Alan Durkin, Ivana Yang, et al.
Annals of Surgical Oncology|November 3, 2006
Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancerMark Bloomston, E Christopher Ellison, Peter Muscarella, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 19, 2006
Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreasMark Bloomston, Peter Muscarella, Manisha H Shah, et al.
Pancreas|September 28, 2006
Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resectionMark Bloomston, Tanios S Bekaii-Saab, Kavitha Kosuri, et al.
Journal of the American College of Surgeons|October 27, 2004
Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumorsAlan J Durkin, Mark Bloomston, Timothy J Yeatman, et al.
Annals of Surgical Oncology|December 31, 2011
Repeat hepatectomy for metastatic colorectal cancer is safe but marginally effectiveNatalie B Jones, Megan E McNally, Lavina Malhotra, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinomaMegan E McNally, Amy Collins, Sylwia E Wojcik, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreasMarisa E Hill, Xiaobai Li, Sharon Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 16, 2013
Gastrectomy in advanced gastric cancer effectively palliates symptoms and may improve survival in select patientsAmy Collins, Ioannis Hatzaras, Carl Schmidt, et al.
Pageof 19